"it's a very exciting time," klugman said. "this is exactly where we would like prenatal diagnosis to go -- to be able to act on it.".
orchid pharma faces liquidation as lenders reject resolution plan
.
.
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)